• About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW
Click Here To Share Your Rare Disease Story
Click Here To Share Your Story With Retinal Vein Occlusion (RVO)
Click Here To Share Your Story With MASH

1514 Search Results Found

You searched for: "study of the week"
  1. Home>
  2. Search results for “study of the week”>
  3. Page 144
Gastroparesis Symptoms Significantly Improved via Gastric Electrical Stimulation

Gastroparesis Symptoms Significantly Improved via Gastric Electrical Stimulation

  Gastric electrical stimulation (GES) has long been suggested as a treatment for symptoms of gastroparesis, but the use of the technique has been deemed controversial. A recent study published…

Continue Reading Gastroparesis Symptoms Significantly Improved via Gastric Electrical Stimulation
The Drug Tofacitinib Appears Effective for Juvenile Idiopathic Arthritis in Clinical Trial

The Drug Tofacitinib Appears Effective for Juvenile Idiopathic Arthritis in Clinical Trial

According to a story from Juvenile Arthritis News, the results of a recent phase 3 clinical trial indicate that the drug tofacitinib (marketed as Xeljanz) can be an effective treatment…

Continue Reading The Drug Tofacitinib Appears Effective for Juvenile Idiopathic Arthritis in Clinical Trial
The Results of This Phase 3 Alport Syndrome Trial Look Promising

The Results of This Phase 3 Alport Syndrome Trial Look Promising

According to a story from Globe Newswire, the biopharmaceutical company Reata Pharmaceuticals, Inc., recently announced the results of a phase 3 clinical trial that was testing its experimental product candidate…

Continue Reading The Results of This Phase 3 Alport Syndrome Trial Look Promising
Revamped Cancer Drug Could Shrink a Multitude of Tumor Types

Revamped Cancer Drug Could Shrink a Multitude of Tumor Types

Cancer tumors need an abundance of different nutrients to grow. Therefore it would make sense that by cutting off the food supply to cancer tumors, we could successfully inhibit their…

Continue Reading Revamped Cancer Drug Could Shrink a Multitude of Tumor Types
“I’m 38. I Can’t Have Parkinson’s:” A Chronic Illness Story From the Czech Republic

“I’m 38. I Can’t Have Parkinson’s:” A Chronic Illness Story From the Czech Republic

It started with fatigue. Then came problems with moving, hand tremors and problems walking. Multiple sclerosis was ruled out by magnetic resonance imaging (MRI). But the trouble didn’t go away.…

Continue Reading “I’m 38. I Can’t Have Parkinson’s:” A Chronic Illness Story From the Czech Republic
The Drug Burosumab Demonstrates Long-Term Benefits for X-Linked Hypophosphatemia

The Drug Burosumab Demonstrates Long-Term Benefits for X-Linked Hypophosphatemia

According to a story from Medscape, the drug burosumab (marketed as Crysvita) demonstrated its ability to provide long term benefits for nearly two years to patients with the rare disease…

Continue Reading The Drug Burosumab Demonstrates Long-Term Benefits for X-Linked Hypophosphatemia
IMFINZI Shows Efficacy for Stage IV Non-Small Cell Lung Cancer

IMFINZI Shows Efficacy for Stage IV Non-Small Cell Lung Cancer

According to a story from us.acrofan.com, the biopharmaceutical company AstraZeneca recently announced the release of positive results for a clinical trial testing the company's drug durvalumab (marketed as IMFINZI) in…

Continue Reading IMFINZI Shows Efficacy for Stage IV Non-Small Cell Lung Cancer
The AI Revolution in Rare Disease Drug Discovery

The AI Revolution in Rare Disease Drug Discovery

A recent announcement by Atomico, one of Europe’s largest venture capital firms based in London, introduced its new partner Healx. The startup can boast of having the world’s most comprehensive…

Continue Reading The AI Revolution in Rare Disease Drug Discovery
  • Go to the previous page
  • 1
  • …
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • …
  • 190
  • Go to the next page
You Are Not Alone: Empowering the Advanced Kidney Cancer Community
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
*cancer that cannot be removed with surgery or has spread to other parts of the body. GEJ= gastroesophageal junction (where the esophagus joins the stomach)
Read Full Story Here
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info